Cyclo Therapeutics Statistics

Total Valuation

CYTH has a market cap or net worth of $18.12 million. The enterprise value is $29.40 million.

Market Cap	18.12M
Enterprise Value	29.40M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

CYTH has 28.77 million shares outstanding. The number of shares has increased by 109.38% in one year.

Current Share Class	28.77M
Shares Outstanding	28.77M
Shares Change (YoY)	+109.38%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	9.23%
Owned by Institutions (%)	7.93%
Float	15.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.56
Forward PS	19.27
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	33.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio	0.17
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-284.27%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$108,841
Profits Per Employee	-$3.10M
Employee Count	8
Asset Turnover	0.16
Inventory Turnover	0.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.93% in the last 52 weeks. The beta is -0.50, so CYTH's price volatility has been lower than the market average.

Beta (5Y)	-0.50
52-Week Price Change	-61.93%
50-Day Moving Average	0.70
200-Day Moving Average	1.06
Relative Strength Index (RSI)	46.85
Average Volume (20 Days)	43,557

Short Selling Information

The latest short interest is 110,697, so 0.38% of the outstanding shares have been sold short.

Short Interest	110,697
Short Previous Month	131,613
Short % of Shares Out	0.38%
Short % of Float	0.71%
Short Ratio (days to cover)	3.82

Income Statement

In the last 12 months, CYTH had revenue of $870,725 and -$24.80 million in losses. Loss per share was -$0.92.

Revenue	870,725
Gross Profit	794,477
Operating Income	-24.68M
Pretax Income	-19.39M
Net Income	-24.80M
EBITDA	-24.67M
EBIT	-24.68M
Loss Per Share	-$0.92

Full Income Statement

Balance Sheet

The company has $928,010 in cash and $12.21 million in debt, giving a net cash position of -$11.28 million or -$0.39 per share.

Cash & Cash Equivalents	928,010
Total Debt	12.21M
Net Cash	-11.28M
Net Cash Per Share	-$0.39
Equity (Book Value)	-13.47M
Book Value Per Share	-0.47
Working Capital	-15.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.52 million and capital expenditures -$2,420, giving a free cash flow of -$22.52 million.

Operating Cash Flow	-22.52M
Capital Expenditures	-2,420
Free Cash Flow	-22.52M
FCF Per Share	-$0.78

Full Cash Flow Statement

Margins

Gross Margin	91.24%
Operating Margin	-2,834.06%
Pretax Margin	-2,848.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CYTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-109.38%
Shareholder Yield	-109.38%
Earnings Yield	-136.83%
FCF Yield	-124.26%

Analyst Forecast

The average price target for CYTH is $0.95, which is 50.79% higher than the current price. The consensus rating is "Buy".

Price Target	$0.95
Price Target Difference	50.79%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 9, 2020. It was a reverse split with a ratio of 0.01:1.

Last Split Date	Dec 9, 2020
Split Type	Reverse
Split Ratio	0.01:1

Scores

CYTH has an Altman Z-Score of -45.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-45.19
Piotroski F-Score	3